Clovis Oncology, Inc. (CLVS): Price and Financial Metrics
Clovis Oncology, Inc. (CLVS)
Today's Latest Price: $5.88 USD
Updated Sep 25 4:00pm
Add CLVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CLVS Stock Summary
- Clovis Oncology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.38% of US listed stocks.
- CLVS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 2.81% of US stocks.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CLVS comes in at -45.03% -- higher than that of just 9.7% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Clovis Oncology Inc are CYTK, NVCN, RMBS, CLSN, and BCYC.
- Visit CLVS's SEC page to see the company's official filings. To visit the company's web site, go to www.clovisoncology.com.
CLVS Stock Price Chart Technical Analysis Charts
CLVS Price/Volume Stats
| Current price | $5.88 | 52-week high | $17.37 |
| Prev. close | $5.70 | 52-week low | $2.93 |
| Day low | $5.58 | Volume | 4,424,276 |
| Day high | $5.93 | Avg. volume | 6,511,509 |
| 50-day MA | $5.86 | Dividend yield | N/A |
| 200-day MA | $7.51 | Market Cap | 518.63M |
Clovis Oncology, Inc. (CLVS) Company Bio
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. The company was founded in 2009 and is based in Boulder, Colorado.
Loading social stream, please wait...